A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Clinical trial NCT07221838 · RECRUITING
Trial details
- NCT number
- NCT07221838
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-04
- Primary completion
- 2027-08-27
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.